Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Clinical trial NCT05420922 · UNKNOWN

Trial details

NCT number: NCT05420922
Sponsor: Tongji Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Programmed Cell Death 1 Effects of Immunotherapy

Start date: 2021-11-01
Primary completion: 2022-08-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.